These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30253067)

  • 1. Mouse Model for Human Vitiligo.
    Riding RL; Richmond JM; Harris JE
    Curr Protoc Immunol; 2019 Feb; 124(1):e63. PubMed ID: 30253067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.
    Harris JE; Harris TH; Weninger W; Wherry EJ; Hunter CA; Turka LA
    J Invest Dermatol; 2012 Jul; 132(7):1869-76. PubMed ID: 22297636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.
    You S; Cho YH; Byun JS; Shin EC
    Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Memory CD8
    Riding RL; Harris JE
    J Immunol; 2019 Jul; 203(1):11-19. PubMed ID: 31209143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo.
    Agarwal P; Rashighi M; Essien KI; Richmond JM; Randall L; Pazoki-Toroudi H; Hunter CA; Harris JE
    J Invest Dermatol; 2015 Apr; 135(4):1080-1088. PubMed ID: 25521459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo.
    Richmond JM; Strassner JP; Rashighi M; Agarwal P; Garg M; Essien KI; Pell LS; Harris JE
    J Invest Dermatol; 2019 Apr; 139(4):769-778. PubMed ID: 30423329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse model of vitiligo induced by monobenzone.
    Zhu Y; Wang S; Xu A
    Exp Dermatol; 2013 Jul; 22(7):499-501. PubMed ID: 23800067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.
    Steitz J; Wenzel J; Gaffal E; Tüting T
    Eur J Cell Biol; 2004 Dec; 83(11-12):797-803. PubMed ID: 15679123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.
    Wańkowicz-Kalińska A; van den Wijngaard RM; Tigges BJ; Westerhof W; Ogg GS; Cerundolo V; Storkus WJ; Das PK
    Lab Invest; 2003 May; 83(5):683-95. PubMed ID: 12746478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.
    Eby JM; Kang HK; Klarquist J; Chatterjee S; Mosenson JA; Nishimura MI; Garrett-Mayer E; Longley BJ; Engelhard VH; Mehrotra S; Le Poole IC
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1075-85. PubMed ID: 24935676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
    Mosenson JA; Zloza A; Nieland JD; Garrett-Mayer E; Eby JM; Huelsmann EJ; Kumar P; Denman CJ; Lacek AT; Kohlhapp FJ; Alamiri A; Hughes T; Bines SD; Kaufman HL; Overbeck A; Mehrotra S; Hernandez C; Nishimura MI; Guevara-Patino JA; Le Poole IC
    Sci Transl Med; 2013 Feb; 5(174):174ra28. PubMed ID: 23447019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model of vitiligo based on endogenous auto-reactive CD8 + T cell targeting skin melanocyte.
    Chen D; Xu Z; Cui J; Chen T
    Cell Regen; 2022 Oct; 11(1):31. PubMed ID: 36182982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.
    Overwijk WW; Lee DS; Surman DR; Irvine KR; Touloukian CE; Chan CC; Carroll MW; Moss B; Rosenberg SA; Restifo NP
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2982-7. PubMed ID: 10077623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative increase in regulatory T cells controls development of vitiligo.
    Chatterjee S; Eby JM; Al-Khami AA; Soloshchenko M; Kang HK; Kaur N; Naga OS; Murali A; Nishimura MI; Caroline Le Poole I; Mehrotra S
    J Invest Dermatol; 2014 May; 134(5):1285-1294. PubMed ID: 24366614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.
    Wu J; Zhou M; Wan Y; Xu A
    Mol Med Rep; 2013 Jan; 7(1):237-41. PubMed ID: 23042234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
    van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
    J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomically distinct fibroblast subsets determine skin autoimmune patterns.
    Xu Z; Chen D; Hu Y; Jiang K; Huang H; Du Y; Wu W; Wang J; Sui J; Wang W; Zhang L; Li S; Li C; Yang Y; Chang J; Chen T
    Nature; 2022 Jan; 601(7891):118-124. PubMed ID: 34912121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
    Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
    J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions.
    Lambe T; Leung JC; Bouriez-Jones T; Silver K; Makinen K; Crockford TL; Ferry H; Forrester JV; Cornall RJ
    J Immunol; 2006 Sep; 177(5):3055-62. PubMed ID: 16920942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.
    Zhou MN; Zhang ZQ; Wu JL; Lin FQ; Fu LF; Wang SQ; Guan CP; Wang HL; Xu A
    PLoS One; 2013; 8(4):e60254. PubMed ID: 23577097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.